Patents for C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334) |
---|
06/10/2010 | WO2010065441A1 Process for preparing hydrocodone using a super acid |
06/10/2010 | WO2010063292A1 Nalmefene hydrochloride dihydrate |
06/10/2010 | US20100145051 N-methylnaltrexone zwitterion |
06/10/2010 | CA2745410A1 Process for preparing hydrocodone using a super acid |
06/10/2010 | CA2744932A1 Nalmefene hydrochloride dihydrate |
06/09/2010 | EP2194059A2 Methods for making 3-O-protected morphinones and 3-O-protected morphinone dienol carboxylates |
06/03/2010 | US20100137598 Process for Preparing Hydrocodone Using a Super Acid |
06/02/2010 | EP2190819A1 Quaternary opioid carboxamides |
05/27/2010 | US20100130524 Therapeutic or prophylactic agent for dyskinesia |
05/27/2010 | US20100130512 Fused-ring heterocycle opioids |
05/26/2010 | EP2189460A1 Improved process for the preparation of 6-alpha-hydroxy-n-alkylated opiates |
05/19/2010 | CN101033228B Method of preparing 14-hydroxy-7,8-dihydromorphone |
05/18/2010 | US7718664 Anti-itching agent |
05/13/2010 | US20100120814 Crystalline and Amorphous Forms of Naltrexone Hydrochloride |
05/13/2010 | US20100120813 Peripheral opioid receptor antagonists and uses thereof |
05/06/2010 | US20100113788 Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates |
05/06/2010 | US20100113787 Preparation of Oxymorphone from Oripavine |
05/06/2010 | US20100113497 Gaba conjugates and methods of use thereof |
04/29/2010 | US20100105911 (S)-N-methylnal trexone |
04/28/2010 | EP2180000A1 Improved process for the preparation of 6-alpha-hydroxy-n-alkylated opiates |
04/28/2010 | EP1421085B1 Process for the preparation of a 14-hydroxynormorphinone derivative |
04/14/2010 | EP2173754A1 Conversion of thebaine to morphine derivatives |
04/08/2010 | WO2010039851A1 Peripheral opioid receptor antagonists and uses thereof |
04/08/2010 | WO2010039222A2 Processes for the selective amination of ketomorphinans |
04/08/2010 | WO2010039221A1 Recycling process for increasing the yield of a grignard reaction in the preparation of opiate alkaloid derivatives |
04/08/2010 | WO2010039220A1 Processes for the production of buprenorphine with reduced impurity formation |
04/08/2010 | WO2010039217A1 Processes for the synthesis of opiate alkaloids with reduced impurity formation |
04/08/2010 | WO2010039216A1 Processes for the alkylation of norbuprenorphine with reduced impurity formation |
04/08/2010 | WO2010039214A1 Processes for increasing the yield of the hydrolysis of the 3-0-methyl and 17-n-nitrile group in the preparation of opiate alkaloid derivatives |
04/08/2010 | WO2010039210A1 Processes for the hydrogenation of opiate alkaloid derivatives |
04/08/2010 | WO2010039209A2 Processes for the synthesis of tertiary amines |
04/08/2010 | CA2738761A1 Processes for the production of buprenorphine with reduced impurity formation |
04/08/2010 | CA2738758A1 Processes for the alkylation of norbuprenorphine with reduced impurity formation |
04/08/2010 | CA2738628A1 Processes for the selective amination of ketomorphinans |
04/08/2010 | CA2738305A1 Processes for the synthesis of opiate alkaloids with reduced impurity formation |
04/08/2010 | CA2738250A1 Processes for increasing the yield of the hydrolysis of the 3-0-methyl and 17-n-nitrile group in the preparation of opiate alkaloid derivatives |
04/08/2010 | CA2738246A1 Processes for the synthesis of tertiary amines |
04/08/2010 | CA2738089A1 Processes for the hydrogenation of opiate alkaloid derivatives |
04/08/2010 | CA2738066A1 Recycling process for increasing the yield of a grignard reaction in the preparation of opiate alkaloid derivatives |
04/07/2010 | EP2170898A1 Methods for n-demethylation of morphine and tropane alkaloids |
04/07/2010 | EP2170897A1 Methods for one-pot n-demethylation/n-acylation of morphine and tropane alkaloids |
04/06/2010 | US7692013 acidification; elution; cost efficiency |
04/01/2010 | US20100081820 Processes for the alkylation of norbuprenorphine with reduced impurity formation |
04/01/2010 | US20100081819 Processes for the synthesis of tertiary amines |
04/01/2010 | US20100081818 Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates |
04/01/2010 | US20100081817 Processes for the selective amination of ketomorphinans |
04/01/2010 | US20100081816 Processes for synthesis of opiate alkaloid derivatives |
04/01/2010 | US20100081815 Recycling process for increasing the yield of opiate alkaloid derivatives |
04/01/2010 | US20100081814 Processes for increasing the yield of opiate alkaloid derivatives |
04/01/2010 | US20100081813 Processes for the synthesis of opiates alkaloids with reduced impurity formation |
03/31/2010 | EP2168580A1 Remedy or preventive for integration dysfunction syndrome |
03/31/2010 | EP2168579A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
03/31/2010 | EP2167506A2 Method for producing n-methylnaltrexone bromide |
03/31/2010 | EP2167505A1 Preparation of n-alkylated opiates by reductive amination |
03/31/2010 | CN101686977A Therapeutic or prophylactic agent for dyskinesia |
03/25/2010 | WO2010033890A1 Polymorphs of 6-beta-naltrexol |
03/25/2010 | WO2010033442A1 Processes for the synthesis of five and six membered heterocyclic rings |
03/25/2010 | US20100076007 Polymorphs of 6-Beta-Naltrexol |
03/25/2010 | CA2737159A1 Processes for the synthesis of five and six membered heterocyclic rings |
03/24/2010 | CN101678016A N-oxides of 4,5-epoxy-morphinanium analogs |
03/23/2010 | US7683170 Methods for preparing Irinotecan |
03/23/2010 | US7683072 Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
03/18/2010 | US20100069639 Processes for the Synthesis of Five and Six Membered Heterocyclic Rings |
03/17/2010 | EP1807433B1 Method for separation and purification of hydrocodone by preparative chromatography |
03/09/2010 | US7674904 Synthesis of R-N-methylnaltrexone |
03/09/2010 | US7674800 Process of salt formation and by-product inhibition; FDA Orange Book listed patent for tradename Oxycontin |
03/09/2010 | US7674799 Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
03/09/2010 | US7674798 Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
03/09/2010 | CA2388395C Compound |
03/02/2010 | US7671204 Oripavine and thebaine, and C(3)-protected hydroxy derivatives of oripavine reacter with ethylchloroformate reacted with an ethyl chloroformate; intermediates for "nal" morphinan compounds such as naltrexone, naloxone, nalbuphene, nalmefene, and buprenorphine |
03/02/2010 | US7671203 Method and system for separation and purification of at least one narcotic alkaloid using reverse phase preparative chromatography |
02/25/2010 | US20100048905 Novel Opiate Reduction Utilizing Catalytic Hydrogen Transfer Reaction |
02/25/2010 | US20100048602 Oligomer-Opioid Agonist Conjugates |
02/24/2010 | EP2156837A1 Crystalline micropowder particles |
02/24/2010 | CN101653411A Controlled release hydrocodone formulations |
02/18/2010 | WO2010017573A1 PROCESS FOR MAKING MORPHINAN-6α-OLS |
02/18/2010 | WO2009132313A3 Morphinan derivatives of organic and inorganic acids |
02/18/2010 | WO2009092073A3 Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
02/18/2010 | US20100041888 Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates |
02/17/2010 | EP2152715A1 Improved process for the preparation of 6-alpha-hydroxy-n-alkylated opiates |
02/17/2010 | CN101652371A Improved method for making analgesics |
02/17/2010 | CN101652370A Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone |
02/17/2010 | CN101652369A Process for reducing impurities in oxycodone base |
02/11/2010 | WO2009092071A3 Amino acid and peptide pro-drugs of phenolic analgesics and uses thereof |
02/11/2010 | US20100036128 PROCESS FOR MAKING MORPHINAN-6alpha-OLS |
02/11/2010 | US20100035910 Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts |
02/10/2010 | EP2151240A1 Therapeutic or prophylactic agent for dyskinesia |
02/10/2010 | EP2150554A1 Solvent-free crystalline form of naltrexone |
02/10/2010 | CN101646676A (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs |
02/10/2010 | CN101646675A Process for the preparation of quaternary N-alkyl morphinan alkaloid salts |
02/04/2010 | WO2010014229A1 Buprenorphine analogs |
02/04/2010 | WO2010013044A1 Nalmefene and derivatives thereof for the treatment of skin disorders |
02/04/2010 | CA2731939A1 Buprenorphine analogs |
02/03/2010 | EP2148864A2 Fused-ring heterocycle opioids |
02/03/2010 | CN100586434C Anti-itching agent |
02/02/2010 | US7655671 Morphinan derivatives, the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof |
01/28/2010 | US20100022774 Process useful in the preparation of morphinan antagonists |
01/27/2010 | EP2147920A2 Process for the preparation of quaternary n-alkyl morphinan alkaloid salts |
01/27/2010 | CN101636400A Processes for synthesizing quaternary 4,5-epoxy-morphinan analogs and isolating their n-stereoisomers |
01/26/2010 | US7652025 Remedies for sepsis |